Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation CarriersElizabeth Page, Manuel R. Teixeira, Eli Marie Grindedal et al.|European Urology|2019Cited by 239
A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damageXueqing Zou, Athanasios Kousathanas, Gene Ching Chiek Koh et al.|Nature Cancer|2021Cited by 165
Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics GroupAmy Taylor, Lucy Side, Angela F. Brady et al.|Journal of Medical Genetics|2018Cited by 101
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective studyElizabeth Bancroft, Alan Donaldson, Elizabeth Page et al.|The Lancet Oncology|2021Cited by 93
Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor PhenotypesJames Whitworth, Philip Smith, Jose‐Ezequiel Martín et al.|The American Journal of Human Genetics|2018Cited by 73